Early Use of Novel Biologics in Psoriatic Arthritis: An Evolving Standard of Care

Hear expert insights on when to use interleukin inhibitors in the course of psoriatic arthritis. Review key data on using these novel agents for DMARD-refractory disease with an on-demand expert presentation and focused commentary.

Share

Program Content

Activities

PsA Axial Manifestations
My Take on Treating Axial Manifestations of Psoriatic Arthritis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 11, 2021

Expires: January 10, 2022

Activities

Video: New Biologics in PsA
Early Use of Novel Biologics in Psoriatic Arthritis: An Evolving Standard of Care
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 29, 2020

Expires: December 28, 2021

Slides: New Biologics in PsA
Slides on Early Use of Novel Biologics in Psoriatic Arthritis: An Evolving Standard of Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 29, 2020

Expires: December 28, 2021

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Novartis Pharmaceuticals Corporation